Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,276,775 | -948,290 | -578,269 | -256,583 | -913,772 |
| Depreciation Amortization | 25,378 | 17,763 | 11,747 | 5,646 | 20,609 |
| Accounts receivable | -88,307 | -11,007 | -781 | 5,361 | -12,932 |
| Accounts payable and accrued liabilities | 100,073 | 9,727 | -35,832 | -61,490 | 44,592 |
| Other Working Capital | -80,299 | -42,656 | -56,552 | -66,090 | -3,177 |
| Other Operating Activity | 384,916 | 287,045 | 192,030 | 111,068 | 180,798 |
| Operating Cash Flow | $-935,014 | $-687,418 | $-467,657 | $-262,088 | $-683,882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32,561 | -15,972 | -13,554 | -10,070 | -21,923 |
| Purchase Of Investment | -2,092,014 | -2,092,014 | -907,199 | -630,518 | -1,577,252 |
| Sale Of Investment | 2,090,000 | 1,654,000 | 1,229,000 | 721,000 | 1,016,000 |
| Other Investing Activity | -30,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-64,575 | $-453,986 | $308,247 | $80,412 | $-583,175 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 150,000 |
| Debt Repayment | -4,926 | -4,150 | -3,403 | -706 | -2,610 |
| Common Stock Issued | 958,999 | 924,364 | 890,207 | 29,704 | 1,197,367 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -3,737 |
| Financing Cash Flow | $954,073 | $920,214 | $886,804 | $28,998 | $1,341,020 |
| Exchange Rate Effect | 931 | 924 | 1,900 | 895 | -1,307 |
| Beginning Cash Position | 555,030 | 555,030 | 555,030 | 555,030 | 482,374 |
| End Cash Position | 510,445 | 334,764 | 1,284,324 | 403,247 | 555,030 |
| Net Cash Flow | $-44,585 | $-220,266 | $729,294 | $-151,783 | $72,656 |
| Free Cash Flow | |||||
| Operating Cash Flow | -935,014 | -687,418 | -467,657 | -262,088 | -683,882 |
| Capital Expenditure | -32,561 | -15,972 | -13,554 | -10,070 | -21,923 |
| Free Cash Flow | -967,575 | -703,390 | -481,211 | -272,158 | -705,805 |